nodes	percent_of_prediction	percent_of_DWPC	metapath
Mequitazine—CYP2D6—Parkinson's disease	0.902	1	CbGaD
Mequitazine—Acetophenazine—DRD1—Parkinson's disease	0.000519	0.0276	CrCbGaD
Mequitazine—Propericiazine—DRD1—Parkinson's disease	0.000458	0.0244	CrCbGaD
Mequitazine—Acetophenazine—DRD2—Parkinson's disease	0.000366	0.0194	CrCbGaD
Mequitazine—Triflupromazine—DRD1—Parkinson's disease	0.000318	0.0169	CrCbGaD
Mequitazine—Acepromazine—DRD1—Parkinson's disease	0.000295	0.0157	CrCbGaD
Mequitazine—Thioproperazine—DRD1—Parkinson's disease	0.000288	0.0153	CrCbGaD
Mequitazine—Mesoridazine—DRD3—Parkinson's disease	0.000285	0.0151	CrCbGaD
Mequitazine—Pipotiazine—DRD1—Parkinson's disease	0.000283	0.0151	CrCbGaD
Mequitazine—Prochlorperazine—DRD3—Parkinson's disease	0.000276	0.0147	CrCbGaD
Mequitazine—Mianserin—HTR7—Parkinson's disease	0.000265	0.0141	CrCbGaD
Mequitazine—Cyamemazine—HTR2A—Parkinson's disease	0.00025	0.0133	CrCbGaD
Mequitazine—Fluphenazine—DRD3—Parkinson's disease	0.000249	0.0133	CrCbGaD
Mequitazine—Mianserin—DRD3—Parkinson's disease	0.000249	0.0133	CrCbGaD
Mequitazine—Fluphenazine—DRD1—Parkinson's disease	0.000245	0.013	CrCbGaD
Mequitazine—Acepromazine—HTR1A—Parkinson's disease	0.000245	0.013	CrCbGaD
Mequitazine—Thioproperazine—HTR1A—Parkinson's disease	0.000239	0.0127	CrCbGaD
Mequitazine—Propiomazine—DRD1—Parkinson's disease	0.000235	0.0125	CrCbGaD
Mequitazine—Pipotiazine—HTR1A—Parkinson's disease	0.000235	0.0125	CrCbGaD
Mequitazine—Mesoridazine—HTR1A—Parkinson's disease	0.000232	0.0123	CrCbGaD
Mequitazine—Mianserin—SLC6A3—Parkinson's disease	0.000232	0.0123	CrCbGaD
Mequitazine—Thioridazine—HTR7—Parkinson's disease	0.000229	0.0121	CrCbGaD
Mequitazine—Triflupromazine—DRD2—Parkinson's disease	0.000224	0.0119	CrCbGaD
Mequitazine—Thioridazine—DRD1—Parkinson's disease	0.000211	0.0112	CrCbGaD
Mequitazine—Perphenazine—HTR7—Parkinson's disease	0.00021	0.0111	CrCbGaD
Mequitazine—Acepromazine—DRD2—Parkinson's disease	0.000208	0.011	CrCbGaD
Mequitazine—Quetiapine—HTR7—Parkinson's disease	0.000206	0.0109	CrCbGaD
Mequitazine—Methotrimeprazine—DRD3—Parkinson's disease	0.000205	0.0109	CrCbGaD
Mequitazine—Fluphenazine—HTR1A—Parkinson's disease	0.000203	0.0108	CrCbGaD
Mequitazine—Mianserin—HTR1A—Parkinson's disease	0.000203	0.0108	CrCbGaD
Mequitazine—Thioproperazine—DRD2—Parkinson's disease	0.000203	0.0108	CrCbGaD
Mequitazine—Methotrimeprazine—DRD1—Parkinson's disease	0.000201	0.0107	CrCbGaD
Mequitazine—Pipotiazine—DRD2—Parkinson's disease	0.0002	0.0106	CrCbGaD
Mequitazine—Mesoridazine—DRD2—Parkinson's disease	0.000197	0.0105	CrCbGaD
Mequitazine—Trimipramine—SLC6A3—Parkinson's disease	0.000195	0.0104	CrCbGaD
Mequitazine—Perphenazine—DRD1—Parkinson's disease	0.000194	0.0103	CrCbGaD
Mequitazine—Quetiapine—DRD3—Parkinson's disease	0.000193	0.0103	CrCbGaD
Mequitazine—Prochlorperazine—DRD2—Parkinson's disease	0.000191	0.0101	CrCbGaD
Mequitazine—Quetiapine—DRD1—Parkinson's disease	0.00019	0.0101	CrCbGaD
Mequitazine—Thioridazine—HTR1A—Parkinson's disease	0.000175	0.00931	CrCbGaD
Mequitazine—Promazine—DRD1—Parkinson's disease	0.000175	0.00927	CrCbGaD
Mequitazine—Fluphenazine—DRD2—Parkinson's disease	0.000173	0.00917	CrCbGaD
Mequitazine—Mianserin—DRD2—Parkinson's disease	0.000173	0.00917	CrCbGaD
Mequitazine—Trimipramine—HTR1A—Parkinson's disease	0.000171	0.00909	CrCbGaD
Mequitazine—Desipramine—SLC6A3—Parkinson's disease	0.000171	0.00907	CrCbGaD
Mequitazine—Chlorpromazine—HTR7—Parkinson's disease	0.000166	0.00884	CrCbGaD
Mequitazine—Fluphenazine—CYP2E1—Parkinson's disease	0.000166	0.00883	CrCbGaD
Mequitazine—Propiomazine—DRD2—Parkinson's disease	0.000166	0.00882	CrCbGaD
Mequitazine—Imipramine—HTR7—Parkinson's disease	0.000166	0.0088	CrCbGaD
Mequitazine—Trifluoperazine—HTR1A—Parkinson's disease	0.000163	0.00864	CrCbGaD
Mequitazine—Perphenazine—HTR1A—Parkinson's disease	0.000161	0.00854	CrCbGaD
Mequitazine—Acepromazine—HTR2A—Parkinson's disease	0.00016	0.00853	CrCbGaD
Mequitazine—Quetiapine—HTR1A—Parkinson's disease	0.000158	0.00838	CrCbGaD
Mequitazine—Thioproperazine—HTR2A—Parkinson's disease	0.000157	0.00833	CrCbGaD
Mequitazine—Chlorpromazine—DRD3—Parkinson's disease	0.000156	0.00831	CrCbGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000155	0.00195	CbGpPWpGaD
Mequitazine—Pipotiazine—HTR2A—Parkinson's disease	0.000154	0.0082	CrCbGaD
Mequitazine—Chlorpromazine—DRD1—Parkinson's disease	0.000154	0.00816	CrCbGaD
Mequitazine—Mesoridazine—HTR2A—Parkinson's disease	0.000152	0.00809	CrCbGaD
Mequitazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000152	0.00192	CbGpPWpGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00015	0.00189	CbGpPWpGaD
Mequitazine—Desipramine—HTR1A—Parkinson's disease	0.00015	0.00795	CrCbGaD
Mequitazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.000149	0.00188	CbGpPWpGaD
Mequitazine—Thioridazine—DRD2—Parkinson's disease	0.000149	0.0079	CrCbGaD
Mequitazine—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000149	0.00188	CbGpPWpGaD
Mequitazine—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000147	0.00185	CbGpPWpGaD
Mequitazine—HRH1—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.000145	0.00184	CbGpPWpGaD
Mequitazine—Trimipramine—DRD2—Parkinson's disease	0.000145	0.00772	CrCbGaD
Mequitazine—Imipramine—SLC6A3—Parkinson's disease	0.000145	0.0077	CrCbGaD
Mequitazine—HRH1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000144	0.00182	CbGpPWpGaD
Mequitazine—Thioridazine—CYP2E1—Parkinson's disease	0.000143	0.0076	CrCbGaD
Mequitazine—HRH1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000143	0.0018	CbGpPWpGaD
Mequitazine—Methotrimeprazine—DRD2—Parkinson's disease	0.000142	0.00754	CrCbGaD
Mequitazine—CHRM2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000141	0.00179	CbGpPWpGaD
Mequitazine—Pipotiazine—CYP2D6—Parkinson's disease	0.000141	0.0075	CrCbGaD
Mequitazine—CHRM2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00014	0.00177	CbGpPWpGaD
Mequitazine—Promethazine—DRD2—Parkinson's disease	0.00014	0.00743	CrCbGaD
Mequitazine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00014	0.00176	CbGpPWpGaD
Mequitazine—Mesoridazine—CYP2D6—Parkinson's disease	0.000139	0.0074	CrCbGaD
Mequitazine—Trifluoperazine—DRD2—Parkinson's disease	0.000138	0.00733	CrCbGaD
Mequitazine—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000138	0.00174	CbGpPWpGaD
Mequitazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000138	0.00174	CbGpPWpGaD
Mequitazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000138	0.00174	CbGpPWpGaD
Mequitazine—Methotrimeprazine—CYP2E1—Parkinson's disease	0.000137	0.00726	CrCbGaD
Mequitazine—Perphenazine—DRD2—Parkinson's disease	0.000136	0.00725	CrCbGaD
Mequitazine—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000136	0.00172	CbGpPWpGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000135	0.00171	CbGpPWpGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000135	0.00171	CbGpPWpGaD
Mequitazine—Prochlorperazine—CYP2D6—Parkinson's disease	0.000135	0.00717	CrCbGaD
Mequitazine—Quetiapine—DRD2—Parkinson's disease	0.000134	0.00711	CrCbGaD
Mequitazine—Fluphenazine—HTR2A—Parkinson's disease	0.000133	0.00709	CrCbGaD
Mequitazine—Mianserin—HTR2A—Parkinson's disease	0.000133	0.00709	CrCbGaD
Mequitazine—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000133	0.00167	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—GRK5—Parkinson's disease	0.000131	0.00166	CbGpPWpGaD
Mequitazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00013	0.00164	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—GRK5—Parkinson's disease	0.000129	0.00163	CbGpPWpGaD
Mequitazine—Propiomazine—HTR2A—Parkinson's disease	0.000128	0.00682	CrCbGaD
Mequitazine—Chlorpromazine—HTR1A—Parkinson's disease	0.000128	0.00678	CrCbGaD
Mequitazine—Desipramine—DRD2—Parkinson's disease	0.000127	0.00675	CrCbGaD
Mequitazine—Imipramine—HTR1A—Parkinson's disease	0.000127	0.00674	CrCbGaD
Mequitazine—HRH1—GPCR ligand binding—HTR1A—Parkinson's disease	0.000124	0.00157	CbGpPWpGaD
Mequitazine—Promazine—DRD2—Parkinson's disease	0.000123	0.00654	CrCbGaD
Mequitazine—Desipramine—CYP2E1—Parkinson's disease	0.000122	0.0065	CrCbGaD
Mequitazine—Fluphenazine—CYP2D6—Parkinson's disease	0.000122	0.00648	CrCbGaD
Mequitazine—Mianserin—CYP2D6—Parkinson's disease	0.000122	0.00648	CrCbGaD
Mequitazine—HRH1—GPCR ligand binding—TAC1—Parkinson's disease	0.000122	0.00154	CbGpPWpGaD
Mequitazine—CHRM2—GPCR ligand binding—HTR1A—Parkinson's disease	0.000122	0.00154	CbGpPWpGaD
Mequitazine—CHRM2—GPCR ligand binding—TAC1—Parkinson's disease	0.00012	0.00152	CbGpPWpGaD
Mequitazine—HRH1—GPCR ligand binding—DRD1—Parkinson's disease	0.00012	0.00151	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—GRK5—Parkinson's disease	0.000119	0.00151	CbGpPWpGaD
Mequitazine—CHRM2—GPCR ligand binding—DRD1—Parkinson's disease	0.000118	0.00149	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—GRM4—Parkinson's disease	0.000118	0.00149	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—GRK5—Parkinson's disease	0.000117	0.00148	CbGpPWpGaD
Mequitazine—HRH1—GPCR ligand binding—DRD3—Parkinson's disease	0.000116	0.00146	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—GRM4—Parkinson's disease	0.000116	0.00146	CbGpPWpGaD
Mequitazine—Thioridazine—HTR2A—Parkinson's disease	0.000115	0.00611	CrCbGaD
Mequitazine—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.000114	0.00144	CbGpPWpGaD
Mequitazine—CHRM2—GPCR ligand binding—DRD3—Parkinson's disease	0.000114	0.00144	CbGpPWpGaD
Mequitazine—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.000114	0.00144	CbGpPWpGaD
Mequitazine—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.000113	0.00143	CbGpPWpGaD
Mequitazine—Triflupromazine—ABCB1—Parkinson's disease	0.000113	0.00602	CrCbGaD
Mequitazine—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000113	0.00142	CbGpPWpGaD
Mequitazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000112	0.00142	CbGpPWpGaD
Mequitazine—Trimipramine—HTR2A—Parkinson's disease	0.000112	0.00596	CrCbGaD
Mequitazine—HRH1—Signaling Pathways—VPS35—Parkinson's disease	0.000112	0.00142	CbGpPWpGaD
Mequitazine—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000112	0.00142	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—PENK—Parkinson's disease	0.000112	0.00141	CbGpPWpGaD
Mequitazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000111	0.0014	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—VPS35—Parkinson's disease	0.00011	0.00139	CbGpPWpGaD
Mequitazine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00011	0.00139	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—PENK—Parkinson's disease	0.00011	0.00139	CbGpPWpGaD
Mequitazine—Methotrimeprazine—HTR2A—Parkinson's disease	0.00011	0.00583	CrCbGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000108	0.00137	CbGpPWpGaD
Mequitazine—Chlorpromazine—DRD2—Parkinson's disease	0.000108	0.00575	CrCbGaD
Mequitazine—Promethazine—HTR2A—Parkinson's disease	0.000108	0.00574	CrCbGaD
Mequitazine—Imipramine—DRD2—Parkinson's disease	0.000108	0.00572	CrCbGaD
Mequitazine—HRH1—Signaling by GPCR—GRM4—Parkinson's disease	0.000107	0.00135	CbGpPWpGaD
Mequitazine—Trifluoperazine—HTR2A—Parkinson's disease	0.000107	0.00567	CrCbGaD
Mequitazine—Perphenazine—HTR2A—Parkinson's disease	0.000105	0.0056	CrCbGaD
Mequitazine—CHRM2—Signaling by GPCR—GRM4—Parkinson's disease	0.000105	0.00133	CbGpPWpGaD
Mequitazine—Thioridazine—CYP2D6—Parkinson's disease	0.000105	0.00558	CrCbGaD
Mequitazine—HRH1—GPCR ligand binding—DRD2—Parkinson's disease	0.000105	0.00132	CbGpPWpGaD
Mequitazine—HRH1—GPCR ligand binding—HTR7—Parkinson's disease	0.000105	0.00132	CbGpPWpGaD
Mequitazine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	0.000104	0.00132	CbGpPWpGaD
Mequitazine—Chlorpromazine—CYP2E1—Parkinson's disease	0.000104	0.00554	CrCbGaD
Mequitazine—Imipramine—CYP2E1—Parkinson's disease	0.000104	0.00551	CrCbGaD
Mequitazine—Quetiapine—HTR2A—Parkinson's disease	0.000103	0.00549	CrCbGaD
Mequitazine—CHRM2—GPCR ligand binding—HTR7—Parkinson's disease	0.000103	0.0013	CbGpPWpGaD
Mequitazine—CHRM2—GPCR ligand binding—DRD2—Parkinson's disease	0.000103	0.0013	CbGpPWpGaD
Mequitazine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000103	0.0013	CbGpPWpGaD
Mequitazine—Trimipramine—CYP2D6—Parkinson's disease	0.000103	0.00545	CrCbGaD
Mequitazine—HRH1—GPCR downstream signaling—PDYN—Parkinson's disease	0.000102	0.00129	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—PENK—Parkinson's disease	0.000101	0.00128	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—PDYN—Parkinson's disease	0.0001	0.00127	CbGpPWpGaD
Mequitazine—Methotrimeprazine—CYP2D6—Parkinson's disease	0.0001	0.00533	CrCbGaD
Mequitazine—CHRM2—Signaling by GPCR—PENK—Parkinson's disease	9.97e-05	0.00126	CbGpPWpGaD
Mequitazine—Promethazine—CYP2D6—Parkinson's disease	9.88e-05	0.00525	CrCbGaD
Mequitazine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	9.85e-05	0.00124	CbGpPWpGaD
Mequitazine—Desipramine—HTR2A—Parkinson's disease	9.81e-05	0.00521	CrCbGaD
Mequitazine—CHRM2—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	9.81e-05	0.00124	CbGpPWpGaD
Mequitazine—CHRM2—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	9.79e-05	0.00124	CbGpPWpGaD
Mequitazine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	9.71e-05	0.00123	CbGpPWpGaD
Mequitazine—Perphenazine—CYP2D6—Parkinson's disease	9.64e-05	0.00512	CrCbGaD
Mequitazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	9.64e-05	0.00122	CbGpPWpGaD
Mequitazine—Promazine—HTR2A—Parkinson's disease	9.51e-05	0.00505	CrCbGaD
Mequitazine—HRH1—GPCR downstream signaling—GRM5—Parkinson's disease	9.49e-05	0.0012	CbGpPWpGaD
Mequitazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	9.48e-05	0.0012	CbGpPWpGaD
Mequitazine—Quetiapine—CYP2D6—Parkinson's disease	9.46e-05	0.00502	CrCbGaD
Mequitazine—CHRM2—GPCR downstream signaling—GRM5—Parkinson's disease	9.33e-05	0.00118	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—DGKQ—Parkinson's disease	9.29e-05	0.00117	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—GPR37—Parkinson's disease	9.29e-05	0.00117	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—PDYN—Parkinson's disease	9.27e-05	0.00117	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—DGKQ—Parkinson's disease	9.14e-05	0.00115	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—GPR37—Parkinson's disease	9.14e-05	0.00115	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—PDYN—Parkinson's disease	9.12e-05	0.00115	CbGpPWpGaD
Mequitazine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	9.01e-05	0.00114	CbGpPWpGaD
Mequitazine—Desipramine—CYP2D6—Parkinson's disease	8.98e-05	0.00477	CrCbGaD
Mequitazine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	8.88e-05	0.00112	CbGpPWpGaD
Mequitazine—Fluphenazine—ABCB1—Parkinson's disease	8.71e-05	0.00463	CrCbGaD
Mequitazine—HRH1—Signaling by GPCR—GRM5—Parkinson's disease	8.61e-05	0.00109	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—PPP1R1B—Parkinson's disease	8.49e-05	0.00107	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—GRM5—Parkinson's disease	8.48e-05	0.00107	CbGpPWpGaD
Mequitazine—HRH1—GPCR ligand binding—EDN1—Parkinson's disease	8.39e-05	0.00106	CbGpPWpGaD
Mequitazine—Chlorpromazine—HTR2A—Parkinson's disease	8.37e-05	0.00445	CrCbGaD
Mequitazine—CHRM2—Signaling Pathways—PPP1R1B—Parkinson's disease	8.36e-05	0.00106	CbGpPWpGaD
Mequitazine—Imipramine—HTR2A—Parkinson's disease	8.32e-05	0.00442	CrCbGaD
Mequitazine—CHRM2—GPCR ligand binding—EDN1—Parkinson's disease	8.25e-05	0.00104	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—ADORA2A—Parkinson's disease	8.07e-05	0.00102	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—ADORA2A—Parkinson's disease	7.94e-05	0.001	CbGpPWpGaD
Mequitazine—Chlorpromazine—CYP2D6—Parkinson's disease	7.65e-05	0.00407	CrCbGaD
Mequitazine—Imipramine—CYP2D6—Parkinson's disease	7.61e-05	0.00404	CrCbGaD
Mequitazine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	7.46e-05	0.000943	CbGpPWpGaD
Mequitazine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	7.43e-05	0.000939	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—RIT2—Parkinson's disease	7.42e-05	0.000938	CbGpPWpGaD
Mequitazine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	7.41e-05	0.000937	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—ND3—Parkinson's disease	7.4e-05	0.000936	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	7.4e-05	0.000936	CbGpPWpGaD
Mequitazine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	7.36e-05	0.00093	CbGpPWpGaD
Mequitazine—HRH1—GPCR ligand binding—HTR2A—Parkinson's disease	7.34e-05	0.000927	CbGpPWpGaD
Mequitazine—Trimipramine—ABCB1—Parkinson's disease	7.33e-05	0.00389	CrCbGaD
Mequitazine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	7.33e-05	0.000926	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—ADORA2A—Parkinson's disease	7.32e-05	0.000926	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—RIT2—Parkinson's disease	7.31e-05	0.000923	CbGpPWpGaD
Mequitazine—CHRM2—GPCR ligand binding—HTR2A—Parkinson's disease	7.22e-05	0.000912	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—ADORA2A—Parkinson's disease	7.21e-05	0.000911	CbGpPWpGaD
Mequitazine—CHRM2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	7.12e-05	0.000899	CbGpPWpGaD
Mequitazine—Promethazine—ABCB1—Parkinson's disease	7.06e-05	0.00375	CrCbGaD
Mequitazine—HRH1—Signaling Pathways—GRK5—Parkinson's disease	7.04e-05	0.00089	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—HTR1A—Parkinson's disease	7e-05	0.000885	CbGpPWpGaD
Mequitazine—Trifluoperazine—ABCB1—Parkinson's disease	6.96e-05	0.0037	CrCbGaD
Mequitazine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	6.96e-05	0.00088	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—OMD—Parkinson's disease	6.96e-05	0.00088	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—GRK5—Parkinson's disease	6.93e-05	0.000875	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—TAC1—Parkinson's disease	6.89e-05	0.000871	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—HTR1A—Parkinson's disease	6.89e-05	0.00087	CbGpPWpGaD
Mequitazine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	6.83e-05	0.000863	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—TAC1—Parkinson's disease	6.78e-05	0.000857	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—DRD1—Parkinson's disease	6.76e-05	0.000854	CbGpPWpGaD
Mequitazine—Quetiapine—ABCB1—Parkinson's disease	6.75e-05	0.00359	CrCbGaD
Mequitazine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	6.73e-05	0.000851	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—DRD1—Parkinson's disease	6.65e-05	0.000841	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	6.6e-05	0.000834	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—DRD3—Parkinson's disease	6.55e-05	0.000827	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—DRD3—Parkinson's disease	6.44e-05	0.000814	CbGpPWpGaD
Mequitazine—Desipramine—ABCB1—Parkinson's disease	6.41e-05	0.00341	CrCbGaD
Mequitazine—HRH1—Signaling by GPCR—HTR1A—Parkinson's disease	6.36e-05	0.000803	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—GRM4—Parkinson's disease	6.31e-05	0.000798	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—GCH1—Parkinson's disease	6.3e-05	0.000796	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—TAC1—Parkinson's disease	6.26e-05	0.000791	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—HTR1A—Parkinson's disease	6.25e-05	0.00079	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—GRM4—Parkinson's disease	6.21e-05	0.000785	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—TAC1—Parkinson's disease	6.16e-05	0.000778	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—DRD1—Parkinson's disease	6.14e-05	0.000776	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.11e-05	0.000773	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—DRD1—Parkinson's disease	6.04e-05	0.000763	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.01e-05	0.00076	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—PENK—Parkinson's disease	5.98e-05	0.000756	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—MAG—Parkinson's disease	5.98e-05	0.000756	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—DRD3—Parkinson's disease	5.94e-05	0.000751	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	5.92e-05	0.000748	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	5.92e-05	0.000748	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—PENK—Parkinson's disease	5.89e-05	0.000744	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—MAG—Parkinson's disease	5.89e-05	0.000744	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	5.85e-05	0.000739	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	5.83e-05	0.000736	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	5.83e-05	0.000736	CbGpPWpGaD
Mequitazine—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	5.74e-05	0.000726	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—GBA—Parkinson's disease	5.61e-05	0.000709	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—FBP1—Parkinson's disease	5.61e-05	0.000709	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—DBH—Parkinson's disease	5.61e-05	0.000709	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	5.55e-05	0.000702	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—PDYN—Parkinson's disease	5.47e-05	0.000692	CbGpPWpGaD
Mequitazine—Chlorpromazine—ABCB1—Parkinson's disease	5.46e-05	0.0029	CrCbGaD
Mequitazine—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	5.46e-05	0.00069	CbGpPWpGaD
Mequitazine—Imipramine—ABCB1—Parkinson's disease	5.44e-05	0.00289	CrCbGaD
Mequitazine—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	5.39e-05	0.000681	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	5.38e-05	0.000679	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	5.38e-05	0.000679	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	5.29e-05	0.000669	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	5.29e-05	0.000669	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—GFAP—Parkinson's disease	5.15e-05	0.00065	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—GRM5—Parkinson's disease	5.09e-05	0.000643	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	5.06e-05	0.00064	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	5.01e-05	0.000633	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—ND3—Parkinson's disease	4.84e-05	0.000612	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	4.84e-05	0.000612	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	4.74e-05	0.000599	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	4.66e-05	0.000589	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	4.55e-05	0.000575	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—OMD—Parkinson's disease	4.55e-05	0.000575	CbGpPWpGaD
Mequitazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	4.52e-05	0.000571	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—FGF20—Parkinson's disease	4.46e-05	0.000564	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	4.39e-05	0.000555	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	4.33e-05	0.000547	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.31e-05	0.000545	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	4.3e-05	0.000544	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	4.26e-05	0.000538	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	4.24e-05	0.000535	CbGpPWpGaD
Mequitazine—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	4.15e-05	0.000524	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—DDC—Parkinson's disease	4.12e-05	0.00052	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—GCH1—Parkinson's disease	4.12e-05	0.00052	CbGpPWpGaD
Mequitazine—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	4.08e-05	0.000516	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—INSR—Parkinson's disease	3.99e-05	0.000505	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—INSR—Parkinson's disease	3.93e-05	0.000497	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	3.89e-05	0.000492	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—FGB—Parkinson's disease	3.77e-05	0.000477	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	3.77e-05	0.000476	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	3.75e-05	0.000474	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—FGB—Parkinson's disease	3.71e-05	0.000469	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	3.71e-05	0.000468	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—TAC1—Parkinson's disease	3.7e-05	0.000467	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	3.69e-05	0.000467	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—GBA—Parkinson's disease	3.67e-05	0.000464	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.67e-05	0.000464	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—DBH—Parkinson's disease	3.67e-05	0.000464	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	3.64e-05	0.00046	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	3.63e-05	0.000458	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	3.57e-05	0.000451	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	3.51e-05	0.000444	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.5e-05	0.000443	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.47e-05	0.000438	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	3.46e-05	0.000437	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	3.28e-05	0.000414	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	3.23e-05	0.000408	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	3.18e-05	0.000401	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	3.18e-05	0.000401	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	3.13e-05	0.000395	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	3.13e-05	0.000395	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—DDC—Parkinson's disease	2.69e-05	0.00034	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	2.66e-05	0.000336	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	2.62e-05	0.000331	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	2.57e-05	0.000325	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.54e-05	0.000321	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	2.54e-05	0.000321	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	2.53e-05	0.00032	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.53e-05	0.00032	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	2.5e-05	0.000316	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.36e-05	0.000298	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—NGF—Parkinson's disease	2.34e-05	0.000295	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.33e-05	0.000294	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—NGF—Parkinson's disease	2.3e-05	0.000291	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—TH—Parkinson's disease	2.3e-05	0.00029	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.29e-05	0.000289	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.27e-05	0.000286	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	2.22e-05	0.000281	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.2e-05	0.000279	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	2.19e-05	0.000277	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—APOE—Parkinson's disease	2.07e-05	0.000261	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—APOE—Parkinson's disease	2.03e-05	0.000257	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—COMT—Parkinson's disease	1.95e-05	0.000247	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.94e-05	0.000246	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.94e-05	0.000245	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.92e-05	0.000242	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.84e-05	0.000232	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.79e-05	0.000226	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—INS—Parkinson's disease	1.77e-05	0.000223	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—INS—Parkinson's disease	1.74e-05	0.00022	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.71e-05	0.000216	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.68e-05	0.000213	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.65e-05	0.000209	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.58e-05	0.000199	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.54e-05	0.000195	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.52e-05	0.000193	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—TH—Parkinson's disease	1.5e-05	0.00019	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—APOE—Parkinson's disease	1.47e-05	0.000186	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.44e-05	0.000182	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	1.32e-05	0.000166	CbGpPWpGaD
Mequitazine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	1.31e-05	0.000165	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	1.29e-05	0.000164	CbGpPWpGaD
Mequitazine—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	1.29e-05	0.000163	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—COMT—Parkinson's disease	1.28e-05	0.000161	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.27e-05	0.000161	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.27e-05	0.00016	CbGpPWpGaD
Mequitazine—CYP2D6—Metabolism—INS—Parkinson's disease	1.26e-05	0.000159	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.25e-05	0.000158	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	1.21e-05	0.000153	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.2e-05	0.000152	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	1.19e-05	0.00015	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.17e-05	0.000148	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.12e-05	0.000141	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.03e-05	0.00013	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—APOE—Parkinson's disease	9.61e-06	0.000121	CbGpPWpGaD
Mequitazine—CYP3A4—Metabolism—INS—Parkinson's disease	8.21e-06	0.000104	CbGpPWpGaD
Mequitazine—HRH1—Signaling Pathways—IL6—Parkinson's disease	7.72e-06	9.76e-05	CbGpPWpGaD
Mequitazine—CHRM2—Signaling Pathways—IL6—Parkinson's disease	7.6e-06	9.6e-05	CbGpPWpGaD
